Guardant Health (GH) Long-Term Investments (2017 - 2022)

Guardant Health has disclosed Long-Term Investments across 6 years of filings, most recently posting $156.7 million for Q3 2022.

• Long-Term Investments for Q3 2022 came in at $156.7 million, down 37.36% year-over-year; the trailing twelve-month figure through Sep 2022 was $156.7 million (down 37.36% YoY), and the FY2021 annual result was $698.0 million, up 183.07% from the prior year.
• Long-Term Investments came in at $156.7 million for Q3 2022 at Guardant Health, down from $382.6 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $698.0 million in Q4 2021 to a low of $3.0 million in Q3 2018.
• The 5-year median for Long-Term Investments is $242.4 million (2020), against an average of $235.6 million.
• Across the five-year window, Long-Term Investments jumped 10113.43% in 2019 and slumped 83.02% in 2020, its largest moves.
• Guardant Health's Long-Term Investments stood at $77.6 million in 2018, then soared by 246.54% to $268.8 million in 2019, then fell by 8.25% to $246.6 million in 2020, then jumped by 183.07% to $698.0 million in 2021, then tumbled by 77.55% to $156.7 million in 2022.
• The last three Long-Term Investments figures came in at $156.7 million (Q3 2022), $382.6 million (Q2 2022), and $588.5 million (Q1 2022), per Business Quant data.